German Chest Pain Unit (CPU)-Register
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01197716|
Recruitment Status : Completed
First Posted : September 9, 2010
Last Update Posted : June 24, 2016
|Condition or disease|
The aim of a Chest Pain Unit (CPU) is to clarify unclear chest pain quickly and specifically. Present data from Germany, the USA and England prove that the organisation models of a CPU lead beside a drastic reduction of mortality also to a cost reduction as well as a shortening of the average inpatient hospital stays.
Therefore it seems reasonable to assign a minimum standard to CPUs. Although there are internationally already standards for CPUs up to complete certification programmes, it is an explicit wish of the German society for cardiology (DGK) to create an own standard which considers on the national circumstances.
The aim of the CPU register is the internal and external validation of the care quality of CPU including Benchmark reports and risk-adjusted comparisons.
|Study Type :||Observational|
|Actual Enrollment :||34470 participants|
|Official Title:||Deutsches CPU-Register. Unterstützt Durch Die Deutsche Gesellschaft für Kardiologie.|
|Study Start Date :||December 2008|
|Primary Completion Date :||December 2015|
|Study Completion Date :||December 2015|
- Internal and external validation of the medical care quality in the field of Chest Pain Units [ Time Frame: hospital stay ]including benchmark reports and risk adjusted comparisons.
- Documentation of CPU complications [ Time Frame: up to 30 hours on average ]including mortality, serious but non-fatal complications (e.g. stroke, heavy and moderate bleedings) as well as documentation of the medication at hospital discharge
- Documentation of long-term mortality and serious but non-fatal complications [ Time Frame: 3 months after discharge ]as well as additional hospital admissions and medication
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01197716
|Study Chair:||Harald Darius, MD||Vivantes Klinikum Neukölln|